| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Neurosurgery [J. E-C., N. B., V. K., P. S. D., D. C., J. M.] and Pathology, Central Pathology Laboratory [J. B.], and Clinical Biochemistry Research Laboratory, School of Postgraduate Medicine, Keele University [A. I., J. A., A. A. F., R. C. S.], North Staffordshire Hospital, Stoke-on-Trent, Staffordshire, United Kingdom ST4 7QB, and Department of Mathematics, Keele University, Staffordshire, United Kingdom [P. J.]
We describe a case-control study to identify associations between polymorphism at the cytochrome P-450 (CYP2D6) and glutathione S-transferase (GSTT1 and GSTM1) loci and susceptibility to astrocytoma and meningioma. Accordingly, genotype frequencies in 112 astrocytoma and 50 meningioma patients were compared with frequencies in 577 controls. GSTM1 genotype frequencies in these groups were not different. Logistic regression analysis showed GSTT1 null and CYP2D6 poor metabolizer were risk factors in astrocytoma (odds ratio = 2.67 P = 0.0005 and odds ratio = 4.17 P = 0.0043, respectively) and meningioma (odds ratio = 4.52, P = 0.0001 and odds ratio = 4.90, P = 0.0132, respectively) when corrected for the other variables. No interactive effects between genotypes were identified. The data suggest polymorphism at loci encoding carcinogen-metabolizing enzymes influences susceptibility to astrocytoma and meningioma, possibly by determining effectiveness in the detoxification of environmental carcinogens.
1 We gratefully acknowledge the support of the North Staffordshire Hospital Neurosurgery Trust Fund.
2 To whom requests for reprints should be addressed.
Received 6/27/95. Accepted 8/18/95.
This article has been cited by other articles:
|
|
 |
|
  B. M. Costa, P. Ferreira, S. Costa, P. Canedo, P. Oliveira, A. Silva, F. Pardal, G. Suriano, J. C. Machado, J. M. Lopes, et al. Association between Functional EGF+61 Polymorphism and Glioma Risk Clin. Cancer Res., May 1, 2007; 13(9): 2621 - 2626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lai, L. Crevier, and L. Thabane Genetic Polymorphisms of Glutathione S-Transferases and the Risk of Adult Brain Tumors: A Meta-analysis Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1784 - 1790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sadetzki, P. Flint-Richter, S. Starinsky, I. Novikov, Y. Lerman, B. Goldman, and E. Friedman Genotyping of Patients with Sporadic and Radiation-Associated Meningiomas Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 969 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hodgson, S. E. Smith, R. C. Strange, and A. A. Fryer Service innovations: Pharmacogenetic clinics in psychiatry: a clinical reality? Psychiatr. Bull., August 1, 2004; 28(8): 298 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S-L. Cheng, C-J. Yu, C-J. Chen, and P-C. Yang Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD Eur. Respir. J., June 1, 2004; 23(6): 818 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wrensch, K. T. Kelsey, M. Liu, R. Miike, M. Moghadassi, K. Aldape, A. McMillan, and J. K. Wiencke Glutathione-S-Transferase Variants and Adult Glioma Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 461 - 467. [Abstract] [Full Text]
|
|
|
|
|
|
P. Barnette, R. Scholl, M. Blandford, L. Ballard, A. Tsodikov, J. Magee, S. Williams, M. Robertson, F. Ali-Osman, R. Lemons, et al. High-Throughput Detection of Glutathione S-Transferase Polymorphic Alleles in a Pediatric Cancer Population Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 304 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. De Roos, N. Rothman, P. D. Inskip, M. S. Linet, W. R. Shapiro, R. G. Selker, H. A. Fine, P. M. Black, G. S. Pittman, and D. A. Bell Genetic Polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the Risk of Adult Brain Tumors Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 14 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. S. Berger Epidemiology of primary brain tumors: Current concepts and review of the literature Neuro-oncol, October 1, 2002; 4(4): 278 - 299. [Abstract] [PDF]
|
|
|
|
|
|
S. M. Davies, L. L. Robison, J. D. Buckley, G. A. Radloff, J. A. Ross, and J. P. Perentesis Glutathione S-Transferase Polymorphisms in Children with Myeloid Leukemia: A Children's Cancer Group Study Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 563 - 566. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y.-C. Hong, H.-S. Park, and E.-H. Ha Influence of genetic susceptibility on the urinary excretion of 8-hydroxydeoxyguanosine of firefighters Occup. Environ. Med., June 1, 2000; 57(6): 370 - 375. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-J. Yim, G. Y. Park, C.-T. Lee, Y. W. Kim, S. K. Han, Y.-S. Shim, and C.-G. Yoo Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1 Thorax, February 1, 2000; 55(2): 121 - 125. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Longuemaux, C. Delomenie, C. Gallou, A. Mejean, M. Vincent-Viry, R. Bouvier, D. Droz, R. Krishnamoorthy, M.-M. Galteau, C. Junien, et al. Candidate Genetic Modifiers of Individual Susceptibility to Renal Cell Carcinoma: A Study of Polymorphic Human Xenobiotic-metabolizing Enzymes Cancer Res., June 1, 1999; 59(12): 2903 - 2908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. J. Nair, J. Nair, B. Mathew, and H. Bartsch Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers Carcinogenesis, May 1, 1999; 20(5): 743 - 748. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
